- Home
- UNCY vs NOTE Comparison
UNCY vs NOTE Comparison
Compare UNCY & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- NOTE
- Stock Information
- Founded
- UNCY 2016
- NOTE 2013
- Country
- UNCY United States
- NOTE United States
- Employees
- UNCY N/A
- NOTE N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- NOTE EDP Services
- Sector
- UNCY Health Care
- NOTE Technology
- Exchange
- UNCY Nasdaq
- NOTE Nasdaq
- Market Cap
- UNCY 74.2M
- NOTE 65.4M
- IPO Year
- UNCY 2021
- NOTE N/A
- Fundamental
- Price
- UNCY $4.93
- NOTE $4.40
- Analyst Decision
- UNCY Strong Buy
- NOTE Strong Buy
- Analyst Count
- UNCY 5
- NOTE 4
- Target Price
- UNCY $55.20
- NOTE $29.25
- AVG Volume (30 Days)
- UNCY 419.1K
- NOTE 289.4K
- Earning Date
- UNCY 11-12-2025
- NOTE 11-11-2025
- Dividend Yield
- UNCY N/A
- NOTE N/A
- EPS Growth
- UNCY N/A
- NOTE N/A
- EPS
- UNCY N/A
- NOTE N/A
- Revenue
- UNCY N/A
- NOTE $109,683,000.00
- Revenue This Year
- UNCY N/A
- NOTE N/A
- Revenue Next Year
- UNCY $19,912.34
- NOTE $41.76
- P/E Ratio
- UNCY N/A
- NOTE N/A
- Revenue Growth
- UNCY N/A
- NOTE N/A
- 52 Week Low
- UNCY $3.71
- NOTE $3.80
- 52 Week High
- UNCY $11.00
- NOTE $24.36
- Technical
- Relative Strength Index (RSI)
- UNCY 66.90
- NOTE 50.19
- Support Level
- UNCY $4.33
- NOTE $4.45
- Resistance Level
- UNCY $4.81
- NOTE $5.08
- Average True Range (ATR)
- UNCY 0.31
- NOTE 0.38
- MACD
- UNCY 0.04
- NOTE -0.17
- Stochastic Oscillator
- UNCY 70.07
- NOTE 3.75
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.